InvestSMART

Atomo Diagnostics Limited (ASX: AT1) - Announcements

- Current share price for AT1 : $0.019

ASX company news and announcements for Atomo Diagnostics Limited (AT1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Atomo Diagnostics Limited (AT1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Atomo Diagnostics Limited (AT1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Atomo Diagnostics Limited (AT1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17 Quarterly Activity Report - 30 September 2022 25 Oct 2022 4:58PM $0.060 $0.019 fallen by 68.33%
$17 Appendix 4C - 30 September 2022 25 Oct 2022 4:57PM $0.060 $0.019 fallen by 68.33%
$17 2022 Annual Report 23 Sep 2022 9:51AM $0.060 $0.019 fallen by 68.33%
$17 2022 Notice of Annual General Meeting 23 Sep 2022 8:26AM $0.060 $0.019 fallen by 68.33%
$17 Atomo FY22 Results Presentation 7 Sep 2022 9:51AM $0.060 $0.019 fallen by 68.33%
$17 Change of Director's Interest Notice - John Kelly 2 Sep 2022 9:28AM $0.062 $0.019 fallen by 69.35%
$17 Notification regarding unquoted securities - AT1 2 Sep 2022 9:24AM $0.062 $0.019 fallen by 69.35%
$17 Notification of cessation of securities - AT1 2 Sep 2022 9:20AM $0.062 $0.019 fallen by 69.35%
$17 2022 Appendix 4G and Corporate Governance Statement 25 Aug 2022 6:32PM $0.073 $0.019 fallen by 73.97%
$17 Investor Webinar and Presentation 25 Aug 2022 5:44PM $0.073 $0.019 fallen by 73.97%
$17 2022 Appendix 4E and Annual Report 25 Aug 2022 5:24PM $0.073 $0.019 fallen by 73.97%
$17 COVID RAT Supply Agreement signed with AllTest & TGA Update 22 Aug 2022 5:17PM $0.072 $0.019 fallen by 73.61%
$17 Quarterly Activity Report - 30 June 2022 29 Jul 2022 8:33AM $0.085 $0.019 fallen by 77.65%
$17 Appendix 4C - 30 June 2022 29 Jul 2022 8:26AM $0.085 $0.019 fallen by 77.65%
$17 Change in substantial holding 14 Jul 2022 6:50PM $0.062 $0.019 fallen by 69.35%
$17 Change in substantial holding 27 May 2022 5:58PM $0.080 $0.019 fallen by 76.25%
$17 Cleansing Statement 6 May 2022 9:11AM $0.105 $0.019 fallen by 81.90%
$17 Application for quotation of securities - AT1 3 May 2022 4:25PM $0.110 $0.019 fallen by 82.73%
$17 Notification regarding unquoted securities - AT1 29 Apr 2022 5:27PM $0.115 $0.019 fallen by 83.48%
$17 Quarterly Activity Report - 31 March 2022 27 Apr 2022 10:26AM $0.120 $0.019 fallen by 84.17%
$17 Appendix 4C - 31 March 2022 27 Apr 2022 9:33AM $0.115 $0.019 fallen by 83.48%
$17 Notification of cessation of securities - AT1 26 Apr 2022 5:21PM $0.115 $0.019 fallen by 83.48%
$17 Atomo expands executive team 26 Apr 2022 12:05PM $0.115 $0.019 fallen by 83.48%
$17 Application for quotation of securities - AT1 19 Apr 2022 9:12AM $0.115 $0.019 fallen by 83.48%
$17 Change of Director's Interest Notice - J Keith 13 Apr 2022 4:51PM $0.115 $0.019 fallen by 83.48%

226 - 250 of 400 results

Page 10 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.